Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26579459
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Acta+Pharm+Sin+B
2015 ; 5
(4
): 300-9
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Current developments in pharmacological therapeutics for chronic constipation
#MMPMID26579459
Jiang C
; Xu Q
; Wen X
; Sun H
Acta Pharm Sin B
2015[Jul]; 5
(4
): 300-9
PMID26579459
show ga
Chronic constipation is a common gastrointestinal disease severely affecting the
patient?s quality of life. The traditional treatment of constipation is the use
of laxatives. Recently, several new drugs including lubiprostone, linaclotide and
prucalopride have been approved for treatment of chronic constipation. However, a
significant unmet medical need still remains, particularly among those patients
achieving poor results by current therapies. The 5-HT4 receptor modulators
velusetrag and naronapride, the guanylate cyclase C agonist plecanatide and the
ileal bile acid transporter inhibitor elobixibat are recognized as the most
promising drugs under investigation. Herein, we give a comprehensive review on
the pharmacological therapeutics for the treatment of chronic constipation, with
the purpose of reflecting the drug development trends in this field.